|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4412 | (2006.01) |
| A61K 31/496 | (2013.01) | ||
| A61K 31/496 | (2006.01) | ||
| A61K 31/4412 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 11/00 | (2018.01) |
| (11) | Number of the document | 3930715 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20710607.1 |
| Date of filing the European patent application | 2020-02-26 | |
| (97) | Date of publication of the European application | 2022-01-05 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2020/051642 |
| Date | 2020-02-26 |
| (87) | Number | WO 2020/174420 |
| Date | 2020-09-03 |
| (30) | Number | Date | Country code |
| 201962811009 P | 2019-02-27 | US |
| (72) |
COUSENS, Leslie , US
NIVENS, Chad , US
ESCOTT, Katherine Jane , GB
MONKLEY, Susan , SE
PRASSE, Antje , DE
|
| (73) |
Astrazeneca AB ,
151 85 Södertälje,
SE
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. , Hansastr. 27c, 80686 München, DE |
| (54) | SARACATINIB FOR USE IN THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS |
| SARACATINIB FOR USE IN THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS |